CKD Bio Corp. (KRX: 063160)

CKD Bio Revenue

CKD Bio had revenue of 42.34B KRW in the quarter ending September 30, 2023, with 12.64% growth. This brings the company's revenue in the last twelve months to 159.93B, up 3.59% year-over-year. In the year 2022, CKD Bio had annual revenue of 156.04B with 9.70% growth.

• Revenue (ttm): 159.93B
• Revenue Growth: +3.59%
• P/S Ratio: 0.76
• Revenue / Employee: 308.16M
• Employees: 519
• Market Cap: 120.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	156.04B	13.80B	9.70%
Dec 31, 2021	142.24B	17.64B	14.16%
Dec 31, 2020	124.60B	-12.58B	-9.17%
Dec 31, 2019	137.18B	12.67B	10.18%
Dec 31, 2018	124.51B	10.75B	9.45%